SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Road Walker who wrote (459237)2/25/2009 10:12:40 AM
From: i-node1 Recommendation  Read Replies (1) of 1573433
 
>> Medicare is prohibited by law from negotiating with drug companies.

Outside of those covered under Part A and a few other incidental situations, Medicare doesn't buy drugs. The 1800 Part D drug companies do. THEY, not MEDICARE, have standing to negotiate with the drug companies.

I've tried to explain this to you time and again and you simply don't get it.

If you take a drug like Neulasta, which is used almost exclusively by Medicare patients, and allow Medicare to take the profit out of that drug, future, better treatments for Neutropenia will not be developed. Because there is no money in it.

That profit motive is the reason we have the best cancer survival rates. AMGEN makes Neulasta in this country. Not in Switzerland.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News